Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Breast Neoplasms

Breast Diseases

Skin Diseases

AeroForm Breast Tissue Expander placed after mastectomy

Breast Tissue Expander using a remote control to fill the expander with Carbon Dioxide

AeroForm Breast Tissue Expander

Tony Connell, F.R.A.C.S.

This study is intended to support previous positive results of the AeroForm™ Patient Controlled Tissue Expander System for breast reconstruction

The objective of this study is to provide performance and safety data to support the clinical use of the AeroForm™ Patient Controlled Tissue Expander System for breast reconstruction in a patient population with a broad selection criteria

Study of AeroForm Tissue Expander for Breast Reconstruction

AeroForm Patient Controlled Tissue Expansion for Breast Reconstruction

AirXpanders, Inc.

136 participants will undergo two-stage reconstruction

tissue expander based breast reconstruction

Breast Tissue Expander

Catalina Solano

Jorge Villalobos

Allan Ramos Esquivel

Luis Picard-Ami

The Motiva Flora® Tissue Expander clinical study (hereafter Motiva Flora® TE study) is a 6-month, open-label, prospective, multicentre post-marketing follow-up study designed to confirm the Safety and Effectiveness/Performance of Motiva Flora® TE in breast reconstruction surgery.

The study will include 136 women, planned for staged breast reconstruction, in 6 countries (Spain, Belgium, France, Costa Rica, Chile and Panama). Breast tissue expansion and the final breast implant will be performed using devices from the Motiva Flora® TE catalogue.

Motiva Flora Tissue Expander PMCF

Post-Marketing Clinical Follow-Up Study to Confirm the Safety and Effectiveness/Performance of Motiva Flora® Tissue Expander in Staged Breast Reconstruction Surgery

Cumulative incidence of the device and procedure-related adverse events as assessed by occurrence, seriousness, severity, causal relationship with the device

Success of the process as perceived by the investigator considering change in final breast volume and comparison with expected volume

Evaluate the time it took to reach the desired expansion following planning.

- Surgeon's overall satisfaction (1=very significant improvement, 2=significant improvement, 3=improvement, 4=no change and 5=decline) at each follow-up visit.

Observation of Integrity of the fixing tabs defined as tabs being intact at explanation with no detachments and cuts.

Motiva Flora® Port locator performance after MRI measured through accurate location defined when the green light on the device comes on

Device interference on MRI measured through artifact size

Radiological Report after undergo CT:

- Interference with CT.

Establishment Labs

AeroForm Tissue Expansion inflation with carbon dioxide by remote control

Saline Tissue Expansion inflated by needle injections of saline

The AeroForm Patient Controlled Tissue Expander is a breast tissue expander implanted following mastectomy and activated by remote control to release small doses of carbon dioxide from an internal reservoir to fill and inflate the expander.

AeroForm Tissue Expansion

A saline tissue expander is a breast tissue expander which is implanted following mastectomy and inflated over time using needle injections to fill and inflate the expander with saline.

Saline Tissue Expansion

Jeffrey A. Ascherman, M.D.

This study is designed to compare the performance and safety of the AirXpander tissue expander to standard saline expanders in patients undergoing two-stage breast reconstruction following mastectomy.

This is a pivotal, prospective, multi-center randomized, controlled, open-label clinical study designed to compare the performance and safety of the AirXpander Tissue Expander System to currently cleared saline tissue expanders. Subject who meet the inclusion and agree to participate in the study will be enrolled and randomized to either the investigational arm (AirXpander Tissue Expander) or the control arm (standard saline tissue expander) using a 2:1 (AirXpander to saline) permuted block randomization stratified by investigational center and procedure (unilateral or bilateral). If the subject is having a bilateral procedure, the same type of expander will be implanted in each side. Subjects in both arms will be followed in the same manner until the explantation of the tissue expander(s) and exchange for permanent implant(s).

Patient Controlled Tissue Expansion for Breast Reconstruction

AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction

The primary endpoint is assessed when the subject has completed tissue expansion and completed an exchange to standard breast implants. Subjects not completing the exchange procedure due to a device related event are considered failures.

The median number of days taken to complete the expansion process.

All AEs collected for the safety cohort (all subjects enrolled and procedure started). In the investigational arm (n=98 treated), the safety cohort includes one untreated subject in which the procedure was started but the device was not implanted due to intra-operative findings (positive nodes). Safety cohort for the investigation arm (n=99).

AEs assessed by investigators for severity, seriousness and relationship to device or procedure.

AEs coded to MedDRA standardized terms.

AeroForm Tissue Expansion inflation with carbon dioxide by remote control

AeroForm Tissue Expansion: The AeroForm Patient Controlled Tissue Expander is a breast tissue expander implanted following mastectomy and activated by remote control to release small doses of carbon dioxide from an internal reservoir to fill and inflate the expander.

Saline Tissue Expansion inflated by needle injections of saline

Saline Tissue Expansion: A saline tissue expander is a breast tissue expander which is implanted following mastectomy and inflated over time using needle injections to fill and inflate the expander with saline.

Total

Age, Categorical

Age, Continuous

Sex: Female, Male

United States

Region of Enrollment

Device improvements occurred during the study with later subjects completing the study with a revised version of the device.

Results include all subjects treated in the study, regardless of device version.

Director of Clinical Affairs

The study was powered to show that the Treatment Success rate for the AeroForm System (πTreatment) was not worse than the rate for the saline expander (πControl) by more than 10% (-0.10 \< πTreatment - πControl).

Primary Analysis Population (Per Protocol Cohort) = Subjects with an expander implanted successfully with no major protocol violation (evaluated per breast). Subjects who had a bilateral procedure have each breast evaluated separately.

Successful Tissue Expansion and Exchange to a Permanent Breast Implant Unless Precluded by a Non-device Related Event

All breasts successfully exchange from expander to standard breast implant were analyzed for the length of time to complete the expansion process (days)

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study of AeroForm Tissue Expander for Breast Reconstruction	NCT01903174	Breast Cancer Breast Reconstr...	AeroForm Breast...	18 Years - 70 Years	AirXpanders, Inc.
Motiva Flora Tissue Expander PMCF	NCT05447988	Breast Tissue A... Breast Cancer	Breast Tissue E...	18 Years -	Establishment Labs
Patient Controlled Tissue Expansion for Breast Reconstruction	NCT01425268	Breast Cancer	AeroForm Tissue... Saline Tissue E...	18 Years - 70 Years	AirXpanders, Inc.

Spots Global Cancer Trial Database for breast tissue expander